Could a stem cell transplant free kidney recipients from a lifetime of anti-rejection drugs?

NCT ID NCT03591302

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests whether a stem cell transplant from the same donor can help people with a functioning kidney transplant stop taking immunosuppressive drugs. Participants receive total lymphoid irradiation and anti-thymocyte globulin to prepare their immune system, followed by an infusion of donor stem cells and T-cells. The goal is to see if the body can accept the kidney without long-term medication. The trial includes adults who have had a kidney transplant from a matched sibling donor for at least one year with no history of rejection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

donor hematopoietic stem cells and T-cells

What this could lead to

If successful, this could allow kidney transplant recipients to stop taking lifelong immunosuppressive drugs without rejecting their kidney.

What could go wrong

This is an early-phase trial with only 25 participants. The conditioning regimen carries risks of infection, graft failure, or rejection, and the approach may not work for everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE TOLERANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University Medical Center

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact